External validation of Cormio nomogram for predicting all prostate cancers and clinically significant prostate cancers
ConclusionWe confirmed that the Cormio nomogram can be used to predict the risk of PCa in patients at increased risk. Implementation of the nomogram in clinical practice will better define its role in the patient ’s counselling before prostate biopsy.
Source: World Journal of Urology - Category: Urology & Nephrology Source Type: research
More News: Cancer | Cancer & Oncology | Italy Health | Pathology | Prostate Cancer | Study | Ultrasound | Urology & Nephrology